PTGX Protagonist Therapeutics Inc

held by 1 manager in Q4 2025

Manager	% of their portfolio	Held	Activity	Value	Shares
Stanley Druckenmiller Duquesne Family Office	0.33%	6 mo	—	$14M	159,700

Search